Hospitalizations for upper and lower GI events associated with traditional NSAIDs and acetaminophen among the elderly in Quebec, Canada

American Journal of Gastroenterology

Volumn 103, Issue 4, 2008, Pages 872-882

  Rahme, Elham ^a,b   Barkun, Alan ^a,b   Nedjar, Hacene ^b   Gaugris, Sabine ^c   Watson, Douglas ^c  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^c MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; CLOPIDOGREL; CORTICOSTEROID; CYCLOOXYGENASE 2 INHIBITOR; MELOXICAM; MISOPROSTOL; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PROTON PUMP INHIBITOR;

ADULT; AGED; ARTICLE; CANADA; CLINICAL TRIAL; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA ANALYSIS; DATA BASE; DEATH; DIGESTIVE SYSTEM PERFORATION; DIGESTIVE SYSTEM ULCER; DYSPEPSIA; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; HEALTH INSURANCE; HEARTBURN; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PAIN; PEPTIC ULCER; PRESCRIPTION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK ASSESSMENT; STATISTICAL MODEL; TIME SERIES ANALYSIS; UPPER GASTROINTESTINAL TRACT;

ACETAMINOPHEN; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DRUG THERAPY, COMBINATION; FEMALE; GASTROINTESTINAL DISEASES; HOSPITALIZATION; HUMANS; MALE; PROPORTIONAL HAZARDS MODELS; PROTON PUMPS; QUEBEC; RETROSPECTIVE STUDIES;

EID: 41849137250     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2008.01811.x     Document Type: Article

References (34)

1. Langford RM. Pain management today-what have we learned? Clin Rheumatol 2006 25 : 2 8.
2. Tannenbaum H, Davis P, Russell AS, et al. An evidence-based approach to prescribing NSAIDs in musculoskeletal disease: A Canadian consensus. CMAJ 1996 155 : 77 88.
3. Tannenbaum H, Peloso PM, Russell AS, et al. An evidence-based approach to prescribing NSAIDs in the treatment of osteoarthritis and rheumatoid arthritis. Can J Clin Pharmacol 2000 7 : 4A.
4. Lanza FL. A guideline for the treatment and prevention of NSAID-induced ulcers. Gastroenterology 1998 93 : 2037 46.
5. Hochberg MC, Altman RD, Brandt KD, et al. Guidelines for the medical management of osteoarthritis. Part II. Osteoarthritis of the knee. American College of Rheumatology. Arthritis Rheum 1995 38 : 1535 46.
6. Hochberg MC, Altman RD, Brandt KD, et al. Guidelines for the medical management of osteoarthritis. Part I. Osteoarthritis of the hip. American College of Rheumatology. Arthritis Rheum 1995 38 : 1535 40.
7. Zhang W, Jones A, Doherty M. Does paracetamol (acetaminophen) reduce the pain of osteoarthritis? A meta-analysis of randomised controlled trials. Ann Rheum Dis 2004 63 : 901 7.
8. Gonzalez-Perez A, Rodriguez LA. Upper gastrointestinal complications among users of paracetamol. Basic Clin Pharmacol Toxicol 2006 98 : 297 303.
9. Garcia Rodriguez LA, Hernandez-Diaz S. Risk of upper gastrointestianl complications among users of acetaminophen and nonsteroidal anti-inflammatory drugs. Epidemiology 2001 12 : 570 6.
10. Towheed TE, Judd MJ, Hochberg MC, et al. Acetaminophen for osteoarthritis. Cochrane Database Syst Rev 2003 : CD004257.
11. Wolfe F, Zhao S, Lane N. Preference for nonsteroidal anti-inflammatory drugs over acetaminophen by rheumatic disease patients: A survey of 1,799 patients with osteoarthritis, rheumatoid arthritis, and fibromyalgia. Arthritis Rheum 2000 43 : 378 85.
12. Wolfe MM, Lichtenstein DR, Singh G. Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. N Engl J Med 1999 340 : 1888 99.
13. Laine L, Connors LG, Reicin A, et al. Serious lower gastrointestinal clinical events with nonselective NSAID or coxib use. Gastroenterology 2003 124 : 288 92.
14. Langman MJ, Morgan L, Worrall A. Use of anti-inflammatory drugs by patients admitted with small or large bowel perforations and haemorrhage. BMJ (Clin Res Ed) 1985 290 : 347 9.
15. Wilcox CM, Alexander LN, Cotsonis GA, et al. Nonsteroidal antiinflammatory drugs are associated with both upper and lower gastrointestinal bleeding. Dig Dis Sci 1997 42 : 990 7.
16. Holt S, Rigoglioso V, Sidhu M, et al. Nonsteroidal antiinflammatory drugs and lower gastrointestinal bleeding. Dig Dis Sci 1993 38 : 1619 23.
17. Kessler WF, Shires GT 3rd., Fahey TJ 3rd. Surgical complications of nonsteroidal antiinflammatory drug-induced small bowel ulceration. J Am Coll Surg 1997 185 : 250 4.
18. Allison MC, Howatson AG, Torrance CJ, et al. Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs. N Engl J Med 1992 327 : 749 54.
19. Silverstein FE, Graham DY, Senior JR, et al. Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized double-blind placebo-controlled trial. Ann Intern Med 1995 123 : 241 9.
20. Yeomans ND, Tulassay Z, Juhasz L, et al. A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group. N Engl J Med 1998 338 : 719 26.
21. Hawkey CJ, Karrasch JA, Szczepanski L, et al. Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group. N Engl J Med 1998 338 : 727 34.
22. Rahme E, Toubouti Y, LeLorier J. Utilization and cost comparison of current and optimal prescribing of nonsteroidal antiinflammatory drugs in Quebec, Canada. J Rheumatol 2006 33 : 588 96.
23. Rahme E, Pettit D, LeLorier J. Determinants and sequelae associated with acetaminophen utilization versus traditional NSAIDs in an elderly population. Arthritis Rheum 2002 46 : 3046 54.
24. Rahme E, Joseph L, Kong SX, et al. Gastrointestinal health care resource use and costs associated with nonsteroidal antiinflammatory drugs versus acetaminophen: Retrospective cohort study of an elderly population. Arthritis Rheum 2000 43 : 917 24.
25. Ake CF, Carpenter AL. Extending the use of PROC PHREG in survival analysis. Proceedings of the 11th Annual Western Users of SAS Software Inc User's Group Conference, 2003 : 1 6.
26. Rahme E, Nedjar H, Bizzi A, et al. Hospitalization for gastrointestinal adverse events attributable to the use of low-dose aspirin among patients 50 years or older also using nonsteroidal anti-inflammatory drugs: A retrospective cohort study. Aliment Pharmacol Ther 2007;26:1387-98.
27. Cryer B, Feldman M. Cyclooxygenase-1 and cyclooxygenase-2 selectivity of widely used nonsteroidal anti-inflammatory drugs. Am J Med 1998 104 : 413 21.
28. Wallace JL, Mcknight W, Reuter BK, et al. NSAID-induced gastric damage in rats: Requirement for inhibition of both cyclooxygenase 1 and 2. Gastroenterology 2000 119 : 706 14.
29. Catella-Lawson F, Reilly MP, Kapoor SC, et al. Cyclooxygenase inhibitors and the antiplatelet effects of aspirin. N Engl J Med 2001 345 : 1809 17.
30. Rainsford KD, Whitehouse MW. Paracetamol (acetaminophen)-induced gastrotoxicity: Revealed by induced hyperacidity in combination with acute or chronic inflammation. Inflammopharmacology 2006 14 : 150 4.
31. Laine L, Smith R, Min K, et al. Systematic review: The lower gastrointestinal adverse effects of non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther 2006 24 : 751 67.
32. Tamblyn R, Lavoie G, Petrella L, et al. The use of prescription claims databases in pharmacoepidemiological research: The accuracy and comprehensiveness of the prescription claims database in Quebec. J Clin Epidemiol 1995 48 : 999 1009.
33. Lewis JD, Kimmel SE, Localio AR, et al. Risk of serious upper gastrointestinal toxicity with over-the-counter nonaspirin nonsteroidal anti-inflammatory drugs. Gastroenterology 2005 129 : 1865 74.
34. Mamdani M, Rochon PA, Juurlink DN, et al. Observational study of upper gastrointestinal haemorrhage in elderly patients given selective cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs. BMJ 2002 325 : 624.